|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:NFRKB-CRTAM (FusionGDB2 ID:58636) |
Fusion Gene Summary for NFRKB-CRTAM |
Fusion gene summary |
Fusion gene information | Fusion gene name: NFRKB-CRTAM | Fusion gene ID: 58636 | Hgene | Tgene | Gene symbol | NFRKB | CRTAM | Gene ID | 4798 | 56253 |
Gene name | nuclear factor related to kappaB binding protein | cytotoxic and regulatory T cell molecule | |
Synonyms | INO80G | CD355 | |
Cytomap | 11q24.3 | 11q24.1 | |
Type of gene | protein-coding | protein-coding | |
Description | nuclear factor related to kappa-B-binding proteinDNA-binding protein R kappa BINO80 complex subunit G | cytotoxic and regulatory T-cell moleculeclass-I MHC-restricted T-cell-associated molecule | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q6P4R8 | O95727 | |
Ensembl transtripts involved in fusion gene | ENST00000446488, ENST00000304521, ENST00000524794, ENST00000524746, ENST00000526940, | ENST00000227348, ENST00000533709, | |
Fusion gene scores | * DoF score | 6 X 7 X 6=252 | 1 X 1 X 1=1 |
# samples | 7 | 1 | |
** MAII score | log2(7/252*10)=-1.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
Context | PubMed: NFRKB [Title/Abstract] AND CRTAM [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | NFRKB(129746616)-CRTAM(122720776), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | NFRKB-CRTAM seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. NFRKB-CRTAM seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | CRTAM | GO:0001913 | T cell mediated cytotoxicity | 15811952 |
Tgene | CRTAM | GO:0002355 | detection of tumor cell | 15811952 |
Tgene | CRTAM | GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 15811952 |
Tgene | CRTAM | GO:0008037 | cell recognition | 15811952 |
Tgene | CRTAM | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity | 15811952 |
Tgene | CRTAM | GO:0050715 | positive regulation of cytokine secretion | 15811952 |
Tgene | CRTAM | GO:0050798 | activated T cell proliferation | 15811952 |
Tgene | CRTAM | GO:0051606 | detection of stimulus | 15811952 |
Fusion gene breakpoints across NFRKB (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across CRTAM (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PAAD | TCGA-XD-AAUI-01A | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + |
Top |
Fusion Gene ORF analysis for NFRKB-CRTAM |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000446488 | ENST00000227348 | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + |
5CDS-intron | ENST00000446488 | ENST00000533709 | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + |
In-frame | ENST00000304521 | ENST00000227348 | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + |
5CDS-intron | ENST00000304521 | ENST00000533709 | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + |
In-frame | ENST00000524794 | ENST00000227348 | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + |
5CDS-intron | ENST00000524794 | ENST00000533709 | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + |
Frame-shift | ENST00000524746 | ENST00000227348 | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + |
5CDS-intron | ENST00000524746 | ENST00000533709 | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + |
intron-3CDS | ENST00000526940 | ENST00000227348 | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + |
intron-intron | ENST00000526940 | ENST00000533709 | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000446488 | NFRKB | chr11 | 129746616 | - | ENST00000227348 | CRTAM | chr11 | 122720776 | + | 4227 | 1851 | 68 | 2986 | 972 |
ENST00000304521 | NFRKB | chr11 | 129746616 | - | ENST00000227348 | CRTAM | chr11 | 122720776 | + | 4283 | 1907 | 46 | 3042 | 998 |
ENST00000524794 | NFRKB | chr11 | 129746616 | - | ENST00000227348 | CRTAM | chr11 | 122720776 | + | 4319 | 1943 | 46 | 3078 | 1010 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000446488 | ENST00000227348 | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + | 0.000344097 | 0.99965596 |
ENST00000304521 | ENST00000227348 | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + | 0.001079172 | 0.9989208 |
ENST00000524794 | ENST00000227348 | NFRKB | chr11 | 129746616 | - | CRTAM | chr11 | 122720776 | + | 0.000982154 | 0.99901783 |
Top |
Fusion Genomic Features for NFRKB-CRTAM |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
NFRKB | chr11 | 129746615 | - | CRTAM | chr11 | 122720775 | + | 0.000123521 | 0.9998765 |
NFRKB | chr11 | 129746615 | - | CRTAM | chr11 | 122720775 | + | 0.000123521 | 0.9998765 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for NFRKB-CRTAM |
Go to FGviewer for the breakpoints of chr11:129746616-chr11:122720776 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
NFRKB | CRTAM |
FUNCTION: Binds to the DNA consensus sequence 5'-GGGGAATCTCC-3'. {ECO:0000269|PubMed:18922472}.; FUNCTION: Putative regulatory component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair. Modulates the deubiquitinase activity of UCHL5 in the INO80 complex. {ECO:0000269|PubMed:18922472}. | FUNCTION: Mediates heterophilic cell-cell adhesion which regulates the activation, differentiation and tissue retention of various T-cell subsets (By similarity). Interaction with CADM1 promotes natural killer (NK) cell cytotoxicity and IFNG/interferon-gamma secretion by CD8+ T-cells in vitro as well as NK cell-mediated rejection of tumors expressing CADM1 in vivo (PubMed:15811952). Regulates CD8+ T-cell proliferation in response to T-cell receptor (TCR) activation (By similarity). Appears to be dispensable for CD8+ T-cell-mediated cytotoxicity (By similarity). Interaction with SCRIB promotes the late phase of cellular polarization of a subset of CD4+ T-cells, which in turn regulates TCR-mediated proliferation and IFNG, IL17 and IL22 production (By similarity). By interacting with CADM1 on CD8+ dendritic cells, regulates the retention of activated CD8+ T-cells within the draining lymph node (By similarity). Required for the intestinal retention of intraepithelial CD4+ CD8+ T-cells and, to a lesser extent, intraepithelial and lamina propria CD8+ T-cells and CD4+ T-cells (By similarity). Interaction with CADM1 promotes the adhesion to gut-associated CD103+ dendritic cells, which may facilitate the expression of gut-homing and adhesion molecules on T-cells and the conversion of CD4+ T-cells into CD4+ CD8+ T-cells (By similarity). {ECO:0000250|UniProtKB:Q149L7, ECO:0000269|PubMed:15811952}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000304521 | - | 15 | 25 | 309_327 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Lys-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000446488 | - | 16 | 26 | 309_327 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Lys-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524746 | - | 17 | 27 | 309_327 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Lys-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524794 | - | 15 | 25 | 309_327 | 607.3333333333334 | 1325.0 | Compositional bias | Note=Lys-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000304521 | - | 15 | 25 | 39_156 | 582.3333333333334 | 1300.0 | Domain | DEUBAD |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000446488 | - | 16 | 26 | 39_156 | 582.3333333333334 | 1300.0 | Domain | DEUBAD |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524746 | - | 17 | 27 | 39_156 | 582.3333333333334 | 1300.0 | Domain | DEUBAD |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524794 | - | 15 | 25 | 39_156 | 607.3333333333334 | 1325.0 | Domain | DEUBAD |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000304521 | - | 15 | 25 | 370_495 | 582.3333333333334 | 1300.0 | Region | Note=Winged-helix like domain |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000446488 | - | 16 | 26 | 370_495 | 582.3333333333334 | 1300.0 | Region | Note=Winged-helix like domain |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524746 | - | 17 | 27 | 370_495 | 582.3333333333334 | 1300.0 | Region | Note=Winged-helix like domain |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524794 | - | 15 | 25 | 370_495 | 607.3333333333334 | 1325.0 | Region | Note=Winged-helix like domain |
Tgene | CRTAM | chr11:129746616 | chr11:122720776 | ENST00000227348 | 0 | 10 | 118_210 | 15.333333333333334 | 394.0 | Domain | Ig-like C2-type | |
Tgene | CRTAM | chr11:129746616 | chr11:122720776 | ENST00000227348 | 0 | 10 | 18_114 | 15.333333333333334 | 394.0 | Domain | Ig-like V-type | |
Tgene | CRTAM | chr11:129746616 | chr11:122720776 | ENST00000533709 | 0 | 5 | 118_210 | 0 | 195.0 | Domain | Ig-like C2-type | |
Tgene | CRTAM | chr11:129746616 | chr11:122720776 | ENST00000533709 | 0 | 5 | 18_114 | 0 | 195.0 | Domain | Ig-like V-type | |
Tgene | CRTAM | chr11:129746616 | chr11:122720776 | ENST00000227348 | 0 | 10 | 390_393 | 15.333333333333334 | 394.0 | Motif | PDZ-binding | |
Tgene | CRTAM | chr11:129746616 | chr11:122720776 | ENST00000533709 | 0 | 5 | 390_393 | 0 | 195.0 | Motif | PDZ-binding | |
Tgene | CRTAM | chr11:129746616 | chr11:122720776 | ENST00000227348 | 0 | 10 | 18_287 | 15.333333333333334 | 394.0 | Topological domain | Extracellular | |
Tgene | CRTAM | chr11:129746616 | chr11:122720776 | ENST00000227348 | 0 | 10 | 309_393 | 15.333333333333334 | 394.0 | Topological domain | Cytoplasmic | |
Tgene | CRTAM | chr11:129746616 | chr11:122720776 | ENST00000533709 | 0 | 5 | 18_287 | 0 | 195.0 | Topological domain | Extracellular | |
Tgene | CRTAM | chr11:129746616 | chr11:122720776 | ENST00000533709 | 0 | 5 | 309_393 | 0 | 195.0 | Topological domain | Cytoplasmic | |
Tgene | CRTAM | chr11:129746616 | chr11:122720776 | ENST00000227348 | 0 | 10 | 288_308 | 15.333333333333334 | 394.0 | Transmembrane | Helical | |
Tgene | CRTAM | chr11:129746616 | chr11:122720776 | ENST00000533709 | 0 | 5 | 288_308 | 0 | 195.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000304521 | - | 15 | 25 | 1245_1271 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Gln-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000304521 | - | 15 | 25 | 665_672 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Poly-Ala |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000304521 | - | 15 | 25 | 684_803 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Ser-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000304521 | - | 15 | 25 | 716_739 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Pro-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000446488 | - | 16 | 26 | 1245_1271 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Gln-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000446488 | - | 16 | 26 | 665_672 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Poly-Ala |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000446488 | - | 16 | 26 | 684_803 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Ser-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000446488 | - | 16 | 26 | 716_739 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Pro-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524746 | - | 17 | 27 | 1245_1271 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Gln-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524746 | - | 17 | 27 | 665_672 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Poly-Ala |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524746 | - | 17 | 27 | 684_803 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Ser-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524746 | - | 17 | 27 | 716_739 | 582.3333333333334 | 1300.0 | Compositional bias | Note=Pro-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524794 | - | 15 | 25 | 1245_1271 | 607.3333333333334 | 1325.0 | Compositional bias | Note=Gln-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524794 | - | 15 | 25 | 665_672 | 607.3333333333334 | 1325.0 | Compositional bias | Note=Poly-Ala |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524794 | - | 15 | 25 | 684_803 | 607.3333333333334 | 1325.0 | Compositional bias | Note=Ser-rich |
Hgene | NFRKB | chr11:129746616 | chr11:122720776 | ENST00000524794 | - | 15 | 25 | 716_739 | 607.3333333333334 | 1325.0 | Compositional bias | Note=Pro-rich |
Top |
Fusion Gene Sequence for NFRKB-CRTAM |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000446488_ENST00000227348_TCGA-XD-AAUI-01A_NFRKB_chr11_129746616_-_CRTAM_chr11_122720776_length(transcript)=4227nt_BP=1851nt CAGGATTCCAGAATTGGAAATAACGGGAGGGAGGACCTGGTCCAGCTTCCCTTCCTCAAATAAGGAAATTGACACCTGGCGTGAGTACCT GTGGAGAAGAAACAATGGATTCCTTAGACCATATGCTGACAGATCCTCTGGAACTTGGTCCGTGTGGAGATGGCCATGGCACGCGCATCA TGGAGGATTGCCTCCTGGGAGGCACCAGAGTTAGTCTGCCCGAGGACCTTCTGGAGGATCCTGAGATCTTCTTTGATGTTGTCAGCCTCT CAACATGGCAGGAAGTGTTAAGTGATTCTCAACGTGAACACCTCCAGCAGTTTCTGCCCCAGTTTCCTGAAGACAGTGCTGAGCAGCAGA ATGAACTCATCTTAGCCTTGTTCAGTGGGGAGAACTTCCGCTTTGGAAACCCTCTGCACATTGCCCAGAAGCTTTTCCGAGACGGACACT TTAACCCCGAGGTGGTCAAGTACCGGCAGTTATGCTTCAAGTCACAGTACAAGCGCTACCTCAACTCCCAGCAGCAGTATTTCCATCGGC TGCTGAAGCAAATTCTTGCTTCCCGGAGTGATCTGCTGGAGATGGCCCGGCGGAGTGGCCCCGCCCTTCCCTTCCGGCAGAAACGCCCTT CACCATCCCGCACACCTGAGGAGCGGGAGTGGCGGACCCAGCAGCGCTACTTGAAGGTCTTAAGGGAAGTGAAAGAGGAGTGTGGTGACA CAGCCCTGTCATCTGATGAAGAGGATCTCAGCTCATGGCTTCCGAGCTCTCCAGCACGTTCTCCTAGTCCTGCGGTGCCCCTGCGGGTGG TGCCCACACTTTCAACCACGGATATGAAAACTGCAGATAAAGTAGAACTGGGGGACAGTGACCTGAAGATAATGTTAAAGAAGCACCACG AGAAGCGGAAACATCAGCCAGATCACCCGGACCTTTTGACAGGGGACCTGACTCTCAATGACATCATGACTCGAGTAAATGCTGGCAGGA AGGGCTCTCTGGCAGCCTTATATGACTTGGCTGTCCTTAAAAAAAAGGTTAAGGAAAAAGAGGAAAAGAAGAAGAAGAAAATAAAAACGA TCAAATCAGAGGCAGAGGACCTGGCCGAGCCGCTAAGCAGTACTGAAGGGGTCGCACCTCTCTCACAGGCCCCCTCTCCGCTGGCAATTC CTGCTATCAAGGAAGAGCCCCTTGAAGACCTCAAGCCTTGCCTTGGAATCAATGAAATATCTTCCAGCTTCTTCTCTCTTCTATTAGAGA TCTTGCTGCTGGAGAGTCAGGCTAGCCTTCCTATGCTAGAGGAGCGAGTTTTGGATTGGCAGTCATCGCCAGCCAGCTCCCTCAACAGCT GGTTCTCTGCGGCCCCCAACTGGGCTGAGTTGGTACTACCAGCCCTGCAGTATCTTGCTGGAGAAAGTCGAGCTGTTCCTTCCAGTTTCT CTCCATTTGTTGAATTCAAAGAGAAAACCCAGCAGTGGAAGTTGCTTGGCCAATCCCAAGATAATGAAAAGGAATTAGCTGCCCTCTTCC AGCTATGGCTAGAGACCAAAGATCAGGCCTTCTGTAAGCAAGAAAATGAAGACAGCTCAGATGCCACAACACCTGTCCCTCGGGTAAGAA CTGACTATGTGGTGCGTCCCAGCACGGGGGAGGAGAAACGGGTTTTTCAGGAGCAGGAGCGTTACAGGTATAGCCAACCCCATAAGGCGT TCACCTTTCGCATGCACGGCTTTGAGTCTGTGGTGGGGCCAGTGAAGGGCGTGTTTGACAAGGAGACCTCGCTCAACAAGGCTCGGGAGC ACTCCCTGCTGCGCTCCGACCGGCCTGCCTACGTCACCATTCTGTCTCTTGAGGCCTCTCTGACTAACCACACAGAAACCATCACCGTGG AGGAAGGCCAGACGCTCACTCTAAAGTGTGTCACTTCTCTGAGGAAGAACTCCTCCCTCCAGTGGCTGACCCCCTCAGGGTTCACCATTT TTTTAAATGAGTATCCTGCTTTAAAAAATTCCAAATACCAGCTTCTTCATCACTCGGCCAATCAGCTCTCCATCACTGTGCCTAACGTAA CCCTGCAAGATGAAGGCGTGTACAAGTGCTTACATTACAGCGACTCTGTAAGCACAAAGGAAGTGAAAGTGATTGTGCTGGCAACTCCTT TCAAGCCAATCCTGGAAGCTTCAGTTATCAGAAAGCAAAATGGAGAAGAACATGTTGTACTCATGTGCTCCACCATGAGAAGCAAGCCCC CTCCGCAGATAACCTGGCTACTTGGGAATAGCATGGAAGTGTCCGGTGGAACGCTCCATGAATTTGAAACTGATGGGAAGAAATGTAATA CTACCAGCACTCTCATAATCCACACTTATGGCAAAAATTCAACGGTGGACTGCATTATCCGACACAGAGGCCTGCAAGGGAGAAAACTAG TAGCACCCTTCCGGTTTGAAGATTTGGTTACTGATGAAGAGACAGCTTCAGATGCTCTGGAGAGAAACTCTCTATCCTCTCAAGACCCAC AGCAGCCCACCAGTACTGTCTCAGTAACGGAAGATTCTAGTACATCGGAGATTGACAAGGAAGAGAAAGAACAAACCACTCAAGATCCTG ACTTGACCACCGAAGCAAATCCTCAGTATTTAGGACTGGCAAGAAAGAAAAGTGGCATCCTGCTGCTCACGCTGGTGTCCTTCCTCATTT TCATACTCTTCATCATAGTCCAGCTCTTCATCATGAAGCTGAGGAAAGCACATGTGATATGGAAGAAAGAAAACGAAGTTTCAGAACACA CACTAGAAAGTTACAGATCAAGGTCAAATAATGAAGAAACATCATCTGAAGAGAAAAATGGCCAATCTTCCCACCCTATGCGTTGCATGA ACTACATCACAAAGTTGTACTCAGAAGCAAAAACAAAGAGGAAGGAAAATGTACAACATTCAAAATTAGAAGAAAAGCACATCCAAGTAC CAGAGAGTATTGTGTAGTGCTCTCTGCAATGGAACATGTGATTTCAGGGTTGCCGCAGTGTCACCTCAGTGGACCAGCCTGGGGGAAGGA GCTTAATTGCTGAGACATTAATAATGACCTCTTAGTGCAATGCAAGATGGTGTCCTCGGATAATGATCTGCCCCGGAGCTAGGGCAGCAA CATGAGGACCAAACCATGCACATAAAGCTTGTAGTTTAAAAAAGAAAAGCAAAAAAATAATTATGCCTGACACTACTTCAGAGCAGGAGG ATTCTACGAAGCCTTGGGGATCAGGGTCAGTGTGAGCAGCTAACATCCTACCTCAAATGGAACAGGATTTTTTGATGCTTTGCTCTAATG GAACTGTTTAAAAAATTTTTTTTTCTTTTTAATATTTTCTTCTGGTCACAAAATAAAGAAATTTGGGATGCAAAGTACCTAAAGATCTCT GATCCTAAGAAGTTACTTCTGGCCAGGCGCGGTGGCTCATGCCTGTAATCCTAGCACTTTGGGAGGCTGAGGTAGGCAGATCACTTGAGG TCAGGAGTTGGAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATGCAAAAATTAGCCAGGCGTAGTGGTGCGCACCTG TAGTCTCAGATACTTGGGAGGCTGAGGGTGGAGAATCGCTTGAACCTGGGAGGTGGAGATTGCAGTGAGTCAAGATCTCACCACTGCACT CCAGCCTGGGCAACAGAGGGAGACTCTGTCTCAAAAAAAAAGAAGTTACTTCCAAGACAGACTTTTAAGATGTAACCAGCACAAAGCAAT GTCAGGGAGGAGTGATACATGACAATAAATGAGTCAGATGAGCAAGAAGGCCCCAGAACCCATGCCCCAAGGCACAAAGAGGAGCTCAGG GTAGGCCCAAAGATTCGAATTCCTTAGATTACTAAATCACATGAGCGGACCTTGTCTGTCAGATAAGATTTTTACCTGGAAATTCCATGA CCAATACATGTGCAAAAGAAAATGATGGGTTGAATTTACTGATTATTGACCTAATGGATGGCTTTTTAAAATGTTTTAATAAAAAGCAGA ATAGATGTTTGTTTTTCTAGTGGTTATACCAAGTTATACTTCCTGTTTTCACGTGTGAAAGTAACATGGGACATGCCTTTCTTTTCCGAT >In-frame_ENST00000446488_ENST00000227348_TCGA-XD-AAUI-01A_NFRKB_chr11_129746616_-_CRTAM_chr11_122720776_length(amino acids)=972AA_start in transcript=68_stop in transcript=2986 MTPGVSTCGEETMDSLDHMLTDPLELGPCGDGHGTRIMEDCLLGGTRVSLPEDLLEDPEIFFDVVSLSTWQEVLSDSQREHLQQFLPQFP EDSAEQQNELILALFSGENFRFGNPLHIAQKLFRDGHFNPEVVKYRQLCFKSQYKRYLNSQQQYFHRLLKQILASRSDLLEMARRSGPAL PFRQKRPSPSRTPEEREWRTQQRYLKVLREVKEECGDTALSSDEEDLSSWLPSSPARSPSPAVPLRVVPTLSTTDMKTADKVELGDSDLK IMLKKHHEKRKHQPDHPDLLTGDLTLNDIMTRVNAGRKGSLAALYDLAVLKKKVKEKEEKKKKKIKTIKSEAEDLAEPLSSTEGVAPLSQ APSPLAIPAIKEEPLEDLKPCLGINEISSSFFSLLLEILLLESQASLPMLEERVLDWQSSPASSLNSWFSAAPNWAELVLPALQYLAGES RAVPSSFSPFVEFKEKTQQWKLLGQSQDNEKELAALFQLWLETKDQAFCKQENEDSSDATTPVPRVRTDYVVRPSTGEEKRVFQEQERYR YSQPHKAFTFRMHGFESVVGPVKGVFDKETSLNKAREHSLLRSDRPAYVTILSLEASLTNHTETITVEEGQTLTLKCVTSLRKNSSLQWL TPSGFTIFLNEYPALKNSKYQLLHHSANQLSITVPNVTLQDEGVYKCLHYSDSVSTKEVKVIVLATPFKPILEASVIRKQNGEEHVVLMC STMRSKPPPQITWLLGNSMEVSGGTLHEFETDGKKCNTTSTLIIHTYGKNSTVDCIIRHRGLQGRKLVAPFRFEDLVTDEETASDALERN SLSSQDPQQPTSTVSVTEDSSTSEIDKEEKEQTTQDPDLTTEANPQYLGLARKKSGILLLTLVSFLIFILFIIVQLFIMKLRKAHVIWKK -------------------------------------------------------------- >In-frame_ENST00000304521_ENST00000227348_TCGA-XD-AAUI-01A_NFRKB_chr11_129746616_-_CRTAM_chr11_122720776_length(transcript)=4283nt_BP=1907nt GCTGTTTAGCTGTAATTAGGGTGCAAGGATAAGGTGTAAGAACTGGCTGGAGGTTGAATGTTTTCCTGGAGGAGTGTTAGCATCAACTAG ATCCCTGGAATTTCTGCCTTTCTGTCTCAAGATGCATGTCTTTGTCCAGAGTACCTGTGGAGAAGAAACAATGGATTCCTTAGACCATAT GCTGACAGATCCTCTGGAACTTGGTCCGTGTGGAGATGGCCATGGCACGCGCATCATGGAGGATTGCCTCCTGGGAGGCACCAGAGTTAG TCTGCCCGAGGACCTTCTGGAGGATCCTGAGATCTTCTTTGATGTTGTCAGCCTCTCAACATGGCAGGAAGTGTTAAGTGATTCTCAACG TGAACACCTCCAGCAGTTTCTGCCCCAGTTTCCTGAAGACAGTGCTGAGCAGCAGAATGAACTCATCTTAGCCTTGTTCAGTGGGGAGAA CTTCCGCTTTGGAAACCCTCTGCACATTGCCCAGAAGCTTTTCCGAGACGGACACTTTAACCCCGAGGTGGTCAAGTACCGGCAGTTATG CTTCAAGTCACAGTACAAGCGCTACCTCAACTCCCAGCAGCAGTATTTCCATCGGCTGCTGAAGCAAATTCTTGCTTCCCGGAGTGATCT GCTGGAGATGGCCCGGCGGAGTGGCCCCGCCCTTCCCTTCCGGCAGAAACGCCCTTCACCATCCCGCACACCTGAGGAGCGGGAGTGGCG GACCCAGCAGCGCTACTTGAAGGTCTTAAGGGAAGTGAAAGAGGAGTGTGGTGACACAGCCCTGTCATCTGATGAAGAGGATCTCAGCTC ATGGCTTCCGAGCTCTCCAGCACGTTCTCCTAGTCCTGCGGTGCCCCTGCGGGTGGTGCCCACACTTTCAACCACGGATATGAAAACTGC AGATAAAGTAGAACTGGGGGACAGTGACCTGAAGATAATGTTAAAGAAGCACCACGAGAAGCGGAAACATCAGCCAGATCACCCGGACCT TTTGACAGGGGACCTGACTCTCAATGACATCATGACTCGAGTAAATGCTGGCAGGAAGGGCTCTCTGGCAGCCTTATATGACTTGGCTGT CCTTAAAAAAAAGGTTAAGGAAAAAGAGGAAAAGAAGAAGAAGAAAATAAAAACGATCAAATCAGAGGCAGAGGACCTGGCCGAGCCGCT AAGCAGTACTGAAGGGGTCGCACCTCTCTCACAGGCCCCCTCTCCGCTGGCAATTCCTGCTATCAAGGAAGAGCCCCTTGAAGACCTCAA GCCTTGCCTTGGAATCAATGAAATATCTTCCAGCTTCTTCTCTCTTCTATTAGAGATCTTGCTGCTGGAGAGTCAGGCTAGCCTTCCTAT GCTAGAGGAGCGAGTTTTGGATTGGCAGTCATCGCCAGCCAGCTCCCTCAACAGCTGGTTCTCTGCGGCCCCCAACTGGGCTGAGTTGGT ACTACCAGCCCTGCAGTATCTTGCTGGAGAAAGTCGAGCTGTTCCTTCCAGTTTCTCTCCATTTGTTGAATTCAAAGAGAAAACCCAGCA GTGGAAGTTGCTTGGCCAATCCCAAGATAATGAAAAGGAATTAGCTGCCCTCTTCCAGCTATGGCTAGAGACCAAAGATCAGGCCTTCTG TAAGCAAGAAAATGAAGACAGCTCAGATGCCACAACACCTGTCCCTCGGGTAAGAACTGACTATGTGGTGCGTCCCAGCACGGGGGAGGA GAAACGGGTTTTTCAGGAGCAGGAGCGTTACAGGTATAGCCAACCCCATAAGGCGTTCACCTTTCGCATGCACGGCTTTGAGTCTGTGGT GGGGCCAGTGAAGGGCGTGTTTGACAAGGAGACCTCGCTCAACAAGGCTCGGGAGCACTCCCTGCTGCGCTCCGACCGGCCTGCCTACGT CACCATTCTGTCTCTTGAGGCCTCTCTGACTAACCACACAGAAACCATCACCGTGGAGGAAGGCCAGACGCTCACTCTAAAGTGTGTCAC TTCTCTGAGGAAGAACTCCTCCCTCCAGTGGCTGACCCCCTCAGGGTTCACCATTTTTTTAAATGAGTATCCTGCTTTAAAAAATTCCAA ATACCAGCTTCTTCATCACTCGGCCAATCAGCTCTCCATCACTGTGCCTAACGTAACCCTGCAAGATGAAGGCGTGTACAAGTGCTTACA TTACAGCGACTCTGTAAGCACAAAGGAAGTGAAAGTGATTGTGCTGGCAACTCCTTTCAAGCCAATCCTGGAAGCTTCAGTTATCAGAAA GCAAAATGGAGAAGAACATGTTGTACTCATGTGCTCCACCATGAGAAGCAAGCCCCCTCCGCAGATAACCTGGCTACTTGGGAATAGCAT GGAAGTGTCCGGTGGAACGCTCCATGAATTTGAAACTGATGGGAAGAAATGTAATACTACCAGCACTCTCATAATCCACACTTATGGCAA AAATTCAACGGTGGACTGCATTATCCGACACAGAGGCCTGCAAGGGAGAAAACTAGTAGCACCCTTCCGGTTTGAAGATTTGGTTACTGA TGAAGAGACAGCTTCAGATGCTCTGGAGAGAAACTCTCTATCCTCTCAAGACCCACAGCAGCCCACCAGTACTGTCTCAGTAACGGAAGA TTCTAGTACATCGGAGATTGACAAGGAAGAGAAAGAACAAACCACTCAAGATCCTGACTTGACCACCGAAGCAAATCCTCAGTATTTAGG ACTGGCAAGAAAGAAAAGTGGCATCCTGCTGCTCACGCTGGTGTCCTTCCTCATTTTCATACTCTTCATCATAGTCCAGCTCTTCATCAT GAAGCTGAGGAAAGCACATGTGATATGGAAGAAAGAAAACGAAGTTTCAGAACACACACTAGAAAGTTACAGATCAAGGTCAAATAATGA AGAAACATCATCTGAAGAGAAAAATGGCCAATCTTCCCACCCTATGCGTTGCATGAACTACATCACAAAGTTGTACTCAGAAGCAAAAAC AAAGAGGAAGGAAAATGTACAACATTCAAAATTAGAAGAAAAGCACATCCAAGTACCAGAGAGTATTGTGTAGTGCTCTCTGCAATGGAA CATGTGATTTCAGGGTTGCCGCAGTGTCACCTCAGTGGACCAGCCTGGGGGAAGGAGCTTAATTGCTGAGACATTAATAATGACCTCTTA GTGCAATGCAAGATGGTGTCCTCGGATAATGATCTGCCCCGGAGCTAGGGCAGCAACATGAGGACCAAACCATGCACATAAAGCTTGTAG TTTAAAAAAGAAAAGCAAAAAAATAATTATGCCTGACACTACTTCAGAGCAGGAGGATTCTACGAAGCCTTGGGGATCAGGGTCAGTGTG AGCAGCTAACATCCTACCTCAAATGGAACAGGATTTTTTGATGCTTTGCTCTAATGGAACTGTTTAAAAAATTTTTTTTTCTTTTTAATA TTTTCTTCTGGTCACAAAATAAAGAAATTTGGGATGCAAAGTACCTAAAGATCTCTGATCCTAAGAAGTTACTTCTGGCCAGGCGCGGTG GCTCATGCCTGTAATCCTAGCACTTTGGGAGGCTGAGGTAGGCAGATCACTTGAGGTCAGGAGTTGGAGACCAGCCTGGCCAACATAGTG AAACCCCGTCTCTACTAAAAATGCAAAAATTAGCCAGGCGTAGTGGTGCGCACCTGTAGTCTCAGATACTTGGGAGGCTGAGGGTGGAGA ATCGCTTGAACCTGGGAGGTGGAGATTGCAGTGAGTCAAGATCTCACCACTGCACTCCAGCCTGGGCAACAGAGGGAGACTCTGTCTCAA AAAAAAAGAAGTTACTTCCAAGACAGACTTTTAAGATGTAACCAGCACAAAGCAATGTCAGGGAGGAGTGATACATGACAATAAATGAGT CAGATGAGCAAGAAGGCCCCAGAACCCATGCCCCAAGGCACAAAGAGGAGCTCAGGGTAGGCCCAAAGATTCGAATTCCTTAGATTACTA AATCACATGAGCGGACCTTGTCTGTCAGATAAGATTTTTACCTGGAAATTCCATGACCAATACATGTGCAAAAGAAAATGATGGGTTGAA TTTACTGATTATTGACCTAATGGATGGCTTTTTAAAATGTTTTAATAAAAAGCAGAATAGATGTTTGTTTTTCTAGTGGTTATACCAAGT TATACTTCCTGTTTTCACGTGTGAAAGTAACATGGGACATGCCTTTCTTTTCCGATCAGTTTATTTAAGCTATACAGCAAACTTTGGCAT >In-frame_ENST00000304521_ENST00000227348_TCGA-XD-AAUI-01A_NFRKB_chr11_129746616_-_CRTAM_chr11_122720776_length(amino acids)=998AA_start in transcript=46_stop in transcript=3042 MEVECFPGGVLASTRSLEFLPFCLKMHVFVQSTCGEETMDSLDHMLTDPLELGPCGDGHGTRIMEDCLLGGTRVSLPEDLLEDPEIFFDV VSLSTWQEVLSDSQREHLQQFLPQFPEDSAEQQNELILALFSGENFRFGNPLHIAQKLFRDGHFNPEVVKYRQLCFKSQYKRYLNSQQQY FHRLLKQILASRSDLLEMARRSGPALPFRQKRPSPSRTPEEREWRTQQRYLKVLREVKEECGDTALSSDEEDLSSWLPSSPARSPSPAVP LRVVPTLSTTDMKTADKVELGDSDLKIMLKKHHEKRKHQPDHPDLLTGDLTLNDIMTRVNAGRKGSLAALYDLAVLKKKVKEKEEKKKKK IKTIKSEAEDLAEPLSSTEGVAPLSQAPSPLAIPAIKEEPLEDLKPCLGINEISSSFFSLLLEILLLESQASLPMLEERVLDWQSSPASS LNSWFSAAPNWAELVLPALQYLAGESRAVPSSFSPFVEFKEKTQQWKLLGQSQDNEKELAALFQLWLETKDQAFCKQENEDSSDATTPVP RVRTDYVVRPSTGEEKRVFQEQERYRYSQPHKAFTFRMHGFESVVGPVKGVFDKETSLNKAREHSLLRSDRPAYVTILSLEASLTNHTET ITVEEGQTLTLKCVTSLRKNSSLQWLTPSGFTIFLNEYPALKNSKYQLLHHSANQLSITVPNVTLQDEGVYKCLHYSDSVSTKEVKVIVL ATPFKPILEASVIRKQNGEEHVVLMCSTMRSKPPPQITWLLGNSMEVSGGTLHEFETDGKKCNTTSTLIIHTYGKNSTVDCIIRHRGLQG RKLVAPFRFEDLVTDEETASDALERNSLSSQDPQQPTSTVSVTEDSSTSEIDKEEKEQTTQDPDLTTEANPQYLGLARKKSGILLLTLVS FLIFILFIIVQLFIMKLRKAHVIWKKENEVSEHTLESYRSRSNNEETSSEEKNGQSSHPMRCMNYITKLYSEAKTKRKENVQHSKLEEKH -------------------------------------------------------------- >In-frame_ENST00000524794_ENST00000227348_TCGA-XD-AAUI-01A_NFRKB_chr11_129746616_-_CRTAM_chr11_122720776_length(transcript)=4319nt_BP=1943nt GCTGTTTAGCTGTAATTAGGGTGCAAGGATAAGGTGTAAGAACTGGCTGGAGGTTGAATGTTTTCCTGGAGGAGTGTTAGCATCAACTAG ATCCCTGGAATTTCTGCCTTTCTGTCTCAAGATGCATGTCTTTGTCCAGAGTACCTGTGGAGAAGAAACAATGGATTCCTTAGACCATAT GCTGACAGATCCTCTGGAACTTGGTCCGTGTGGAGATGGCCATGGCACGCGCATCATGGAGGATTGCCTCCTGGGAGGCACCAGAGTTAG TCTGCCCGAGGACCTTCTGGAGGATCCTGAGATCTTCTTTGATGTTGTCAGCCTCTCAACATGGCAGGAAGTGTTAAGTGATTCTCAACG TGAACACCTCCAGCAGTTTCTGCCCCAGTTTCCTGAAGACAGTGCTGAGCAGCAGAATGAACTCATCTTAGCCTTGTTCAGTGGGGAGAA CTTCCGCTTTGGAAACCCTCTGCACATTGCCCAGAAGCTTTTCCGAGACGGACACTTTAACCCCGAGGTGGTCAAGTACCGGCAGTTATG CTTCAAGTCACAGTACAAGCGCTACCTCAACTCCCAGCAGCAGTATTTCCATCGGCTGCTGAAGCAAATTCTTGCTTCCCGGAGTGATCT GCTGGAGATGGCCCGGCGGAGTGGCCCCGCCCTTCCCTTCCGGCAGAAACGCCCTTCACCATCCCGCACACCTGAGGAGCGGGAGTGGCG GACCCAGCAGCGCTACTTGAAGGTCTTAAGGGAAGTGAAAGAGGAGTGTGGTGACACAGCCCTGTCATCTGATGAAGAGGCCACGTTGGA TTTACAAGAACAATTTTCTTTTGAAGATCTCAGCTCATGGCTTCCGAGCTCTCCAGCACGTTCTCCTAGTCCTGCGGTGCCCCTGCGGGT GGTGCCCACACTTTCAACCACGGATATGAAAACTGCAGATAAAGTAGAACTGGGGGACAGTGACCTGAAGATAATGTTAAAGAAGCACCA CGAGAAGCGGAAACATCAGCCAGATCACCCGGACCTTTTGACAGGGGACCTGACTCTCAATGACATCATGACTCGAGTAAATGCTGGCAG GAAGGGCTCTCTGGCAGCCTTATATGACTTGGCTGTCCTTAAAAAAAAGGTTAAGGAAAAAGAGGAAAAGAAGAAGAAGAAAATAAAAAC GATCAAATCAGAGGCAGAGGACCTGGCCGAGCCGCTAAGCAGTACTGAAGGGGTCGCACCTCTCTCACAGGCCCCCTCTCCGCTGGCAAT TCCTGCTATCAAGGAAGAGCCCCTTGAAGACCTCAAGCCTTGCCTTGGAATCAATGAAATATCTTCCAGCTTCTTCTCTCTTCTATTAGA GATCTTGCTGCTGGAGAGTCAGGCTAGCCTTCCTATGCTAGAGGAGCGAGTTTTGGATTGGCAGTCATCGCCAGCCAGCTCCCTCAACAG CTGGTTCTCTGCGGCCCCCAACTGGGCTGAGTTGGTACTACCAGCCCTGCAGTATCTTGCTGGAGAAAGTCGAGCTGTTCCTTCCAGTTT CTCTCCATTTGTTGAATTCAAAGAGAAAACCCAGCAGTGGAAGTTGCTTGGCCAATCCCAAGATAATGAAAAGGAATTAGCTGCCCTCTT CCAGCTATGGCTAGAGACCAAAGATCAGGCCTTCTGTAAGCAAGAAAATGAAGACAGCTCAGATGCCACAACACCTGTCCCTCGGGTAAG AACTGACTATGTGGTGCGTCCCAGCACGGGGGAGGAGAAACGGGTTTTTCAGGAGCAGGAGCGTTACAGGTATAGCCAACCCCATAAGGC GTTCACCTTTCGCATGCACGGCTTTGAGTCTGTGGTGGGGCCAGTGAAGGGCGTGTTTGACAAGGAGACCTCGCTCAACAAGGCTCGGGA GCACTCCCTGCTGCGCTCCGACCGGCCTGCCTACGTCACCATTCTGTCTCTTGAGGCCTCTCTGACTAACCACACAGAAACCATCACCGT GGAGGAAGGCCAGACGCTCACTCTAAAGTGTGTCACTTCTCTGAGGAAGAACTCCTCCCTCCAGTGGCTGACCCCCTCAGGGTTCACCAT TTTTTTAAATGAGTATCCTGCTTTAAAAAATTCCAAATACCAGCTTCTTCATCACTCGGCCAATCAGCTCTCCATCACTGTGCCTAACGT AACCCTGCAAGATGAAGGCGTGTACAAGTGCTTACATTACAGCGACTCTGTAAGCACAAAGGAAGTGAAAGTGATTGTGCTGGCAACTCC TTTCAAGCCAATCCTGGAAGCTTCAGTTATCAGAAAGCAAAATGGAGAAGAACATGTTGTACTCATGTGCTCCACCATGAGAAGCAAGCC CCCTCCGCAGATAACCTGGCTACTTGGGAATAGCATGGAAGTGTCCGGTGGAACGCTCCATGAATTTGAAACTGATGGGAAGAAATGTAA TACTACCAGCACTCTCATAATCCACACTTATGGCAAAAATTCAACGGTGGACTGCATTATCCGACACAGAGGCCTGCAAGGGAGAAAACT AGTAGCACCCTTCCGGTTTGAAGATTTGGTTACTGATGAAGAGACAGCTTCAGATGCTCTGGAGAGAAACTCTCTATCCTCTCAAGACCC ACAGCAGCCCACCAGTACTGTCTCAGTAACGGAAGATTCTAGTACATCGGAGATTGACAAGGAAGAGAAAGAACAAACCACTCAAGATCC TGACTTGACCACCGAAGCAAATCCTCAGTATTTAGGACTGGCAAGAAAGAAAAGTGGCATCCTGCTGCTCACGCTGGTGTCCTTCCTCAT TTTCATACTCTTCATCATAGTCCAGCTCTTCATCATGAAGCTGAGGAAAGCACATGTGATATGGAAGAAAGAAAACGAAGTTTCAGAACA CACACTAGAAAGTTACAGATCAAGGTCAAATAATGAAGAAACATCATCTGAAGAGAAAAATGGCCAATCTTCCCACCCTATGCGTTGCAT GAACTACATCACAAAGTTGTACTCAGAAGCAAAAACAAAGAGGAAGGAAAATGTACAACATTCAAAATTAGAAGAAAAGCACATCCAAGT ACCAGAGAGTATTGTGTAGTGCTCTCTGCAATGGAACATGTGATTTCAGGGTTGCCGCAGTGTCACCTCAGTGGACCAGCCTGGGGGAAG GAGCTTAATTGCTGAGACATTAATAATGACCTCTTAGTGCAATGCAAGATGGTGTCCTCGGATAATGATCTGCCCCGGAGCTAGGGCAGC AACATGAGGACCAAACCATGCACATAAAGCTTGTAGTTTAAAAAAGAAAAGCAAAAAAATAATTATGCCTGACACTACTTCAGAGCAGGA GGATTCTACGAAGCCTTGGGGATCAGGGTCAGTGTGAGCAGCTAACATCCTACCTCAAATGGAACAGGATTTTTTGATGCTTTGCTCTAA TGGAACTGTTTAAAAAATTTTTTTTTCTTTTTAATATTTTCTTCTGGTCACAAAATAAAGAAATTTGGGATGCAAAGTACCTAAAGATCT CTGATCCTAAGAAGTTACTTCTGGCCAGGCGCGGTGGCTCATGCCTGTAATCCTAGCACTTTGGGAGGCTGAGGTAGGCAGATCACTTGA GGTCAGGAGTTGGAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATGCAAAAATTAGCCAGGCGTAGTGGTGCGCACC TGTAGTCTCAGATACTTGGGAGGCTGAGGGTGGAGAATCGCTTGAACCTGGGAGGTGGAGATTGCAGTGAGTCAAGATCTCACCACTGCA CTCCAGCCTGGGCAACAGAGGGAGACTCTGTCTCAAAAAAAAAGAAGTTACTTCCAAGACAGACTTTTAAGATGTAACCAGCACAAAGCA ATGTCAGGGAGGAGTGATACATGACAATAAATGAGTCAGATGAGCAAGAAGGCCCCAGAACCCATGCCCCAAGGCACAAAGAGGAGCTCA GGGTAGGCCCAAAGATTCGAATTCCTTAGATTACTAAATCACATGAGCGGACCTTGTCTGTCAGATAAGATTTTTACCTGGAAATTCCAT GACCAATACATGTGCAAAAGAAAATGATGGGTTGAATTTACTGATTATTGACCTAATGGATGGCTTTTTAAAATGTTTTAATAAAAAGCA GAATAGATGTTTGTTTTTCTAGTGGTTATACCAAGTTATACTTCCTGTTTTCACGTGTGAAAGTAACATGGGACATGCCTTTCTTTTCCG >In-frame_ENST00000524794_ENST00000227348_TCGA-XD-AAUI-01A_NFRKB_chr11_129746616_-_CRTAM_chr11_122720776_length(amino acids)=1010AA_start in transcript=46_stop in transcript=3078 MEVECFPGGVLASTRSLEFLPFCLKMHVFVQSTCGEETMDSLDHMLTDPLELGPCGDGHGTRIMEDCLLGGTRVSLPEDLLEDPEIFFDV VSLSTWQEVLSDSQREHLQQFLPQFPEDSAEQQNELILALFSGENFRFGNPLHIAQKLFRDGHFNPEVVKYRQLCFKSQYKRYLNSQQQY FHRLLKQILASRSDLLEMARRSGPALPFRQKRPSPSRTPEEREWRTQQRYLKVLREVKEECGDTALSSDEEATLDLQEQFSFEDLSSWLP SSPARSPSPAVPLRVVPTLSTTDMKTADKVELGDSDLKIMLKKHHEKRKHQPDHPDLLTGDLTLNDIMTRVNAGRKGSLAALYDLAVLKK KVKEKEEKKKKKIKTIKSEAEDLAEPLSSTEGVAPLSQAPSPLAIPAIKEEPLEDLKPCLGINEISSSFFSLLLEILLLESQASLPMLEE RVLDWQSSPASSLNSWFSAAPNWAELVLPALQYLAGESRAVPSSFSPFVEFKEKTQQWKLLGQSQDNEKELAALFQLWLETKDQAFCKQE NEDSSDATTPVPRVRTDYVVRPSTGEEKRVFQEQERYRYSQPHKAFTFRMHGFESVVGPVKGVFDKETSLNKAREHSLLRSDRPAYVTIL SLEASLTNHTETITVEEGQTLTLKCVTSLRKNSSLQWLTPSGFTIFLNEYPALKNSKYQLLHHSANQLSITVPNVTLQDEGVYKCLHYSD SVSTKEVKVIVLATPFKPILEASVIRKQNGEEHVVLMCSTMRSKPPPQITWLLGNSMEVSGGTLHEFETDGKKCNTTSTLIIHTYGKNST VDCIIRHRGLQGRKLVAPFRFEDLVTDEETASDALERNSLSSQDPQQPTSTVSVTEDSSTSEIDKEEKEQTTQDPDLTTEANPQYLGLAR KKSGILLLTLVSFLIFILFIIVQLFIMKLRKAHVIWKKENEVSEHTLESYRSRSNNEETSSEEKNGQSSHPMRCMNYITKLYSEAKTKRK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for NFRKB-CRTAM |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for NFRKB-CRTAM |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for NFRKB-CRTAM |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |